Perrigo Gets Tentative FDA Approval For Generic Acne Drug

Perrigo Company has received tentative approval from the US Food and Drug Administration for the generic version of Epiduo Gel (adapalene and benzoyl peroxide 0.1%/2.5%), a drug to treat acne vulgaris in patients 12 years of age and older.

Annual sales for Epiduo Gel for the 12 months ending July 2016 were $379 million, according to Perrigo.

Source: Perrigo

Leave a Reply

Your email address will not be published. Required fields are marked *